S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
20 Best Healthcare Dividend Stocks to Invest in
How to Invest in AI's Fast-Growing Market (Ad)
Nordstrom's Earnings Beat, A Rally In The Making
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
How to Invest in AI's Fast-Growing Market (Ad)
What is the Penalty for Excess Contributions to an IRA?
Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
How to Invest in AI's Fast-Growing Market (Ad)
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
Okta, Inc: When Great Results Aren’t Good Enough 
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
20 Best Healthcare Dividend Stocks to Invest in
How to Invest in AI's Fast-Growing Market (Ad)
Nordstrom's Earnings Beat, A Rally In The Making
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
How to Invest in AI's Fast-Growing Market (Ad)
What is the Penalty for Excess Contributions to an IRA?
Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
How to Invest in AI's Fast-Growing Market (Ad)
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
Okta, Inc: When Great Results Aren’t Good Enough 
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
20 Best Healthcare Dividend Stocks to Invest in
How to Invest in AI's Fast-Growing Market (Ad)
Nordstrom's Earnings Beat, A Rally In The Making
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
How to Invest in AI's Fast-Growing Market (Ad)
What is the Penalty for Excess Contributions to an IRA?
Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
How to Invest in AI's Fast-Growing Market (Ad)
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
Okta, Inc: When Great Results Aren’t Good Enough 
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
20 Best Healthcare Dividend Stocks to Invest in
How to Invest in AI's Fast-Growing Market (Ad)
Nordstrom's Earnings Beat, A Rally In The Making
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
How to Invest in AI's Fast-Growing Market (Ad)
What is the Penalty for Excess Contributions to an IRA?
Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
How to Invest in AI's Fast-Growing Market (Ad)
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
Okta, Inc: When Great Results Aren’t Good Enough 
ETR:GXI

Gerresheimer (GXI) Stock Forecast, Price & News

€104.30
+1.50 (+1.46%)
(As of 06/1/2023 ET)
Compare
Today's Range
€102.20
▼
€104.30
50-Day Range
€87.25
▼
€104.30
52-Week Range
€46.66
▼
€104.50
Volume
78,804 shs
Average Volume
140,925 shs
Market Capitalization
$3.28 billion
P/E Ratio
31.80
Dividend Yield
1.20%
Price Target
€104.12
ProfileAnalyst RatingsChartCompetitorsHeadlines

GXI stock logo

About Gerresheimer (ETR:GXI) Stock

Gerresheimer AG, together with its subsidiaries, manufactures and sells packaging products, and drug delivery-devices and solutions worldwide. It operates through Plastics & Devices, Primary Packaging Glass, and Advanced Technologies divisions. The Plastics & Devices division offers drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic systems for the pharma, biotech, diagnostics, and medical technology industries; containers and closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators, and accessories for solid, liquid, and ophthalmic applications; and bottles and containers for nutritional supplements. The Primary Packaging Glass division offers glass primary packaging for pharma and cosmetics industries, such as infusion, dropper, and syrup bottles; injection vials, ampoules, and cartridges; miniature bottles and glass containers for liquid food, spices, and spirits; and packaging solutions for fragrances, deodorants, skin care, and wellness products, as well as beauty and pharmaceutical products. The Advanced Technologies division develops smart drug delivery systems, such as micro pumps, which are used to self-administer medication for Parkinson's disease or heart failure to pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.

Receive GXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gerresheimer and its competitors with MarketBeat's FREE daily newsletter.

GXI Stock News Headlines

May 12, 2023 | finance.yahoo.com
Is Gerresheimer AG's (ETR:GXI) 8.8% ROE Better Than Average?
April 25, 2023 | finance.yahoo.com
Gerresheimer's (ETR:GXI) investors will be pleased with their favorable 43% return over the last five years
June 2, 2023 | Edge On The Street (Ad)
How to Invest in AI's Fast-Growing Market
The AI market stands at $160 billion in 2023. Estimates are the AI market will grow 20-fold to $1.8 TRILLION by 2030. One little-known company is looking to win big with a new network technology no one else has. AI could explode... and soon.
April 21, 2023 | msn.com
BERENBERG Maintains Gerresheimer (FWB:GXI) Buy Recommendation
April 5, 2023 | finance.yahoo.com
Gerresheimer (ETR:GXI) Is Paying Out A Dividend Of €1.25
March 26, 2023 | americanbankingnews.com
Gerresheimer (ETR:GXI) PT Set at €144.10 by JPMorgan Chase & Co.
March 25, 2023 | americanbankingnews.com
Gerresheimer (ETR:GXI) PT Set at €110.00 by Deutsche Bank Aktiengesellschaft
February 27, 2023 | finance.yahoo.com
Gerresheimer (ETR:GXI) Has Announced A Dividend Of €1.25
June 2, 2023 | Edge On The Street (Ad)
How to Invest in AI's Fast-Growing Market
The AI market stands at $160 billion in 2023. Estimates are the AI market will grow 20-fold to $1.8 TRILLION by 2030. One little-known company is looking to win big with a new network technology no one else has. AI could explode... and soon.
February 26, 2023 | yahoo.com
Gerresheimer Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags
December 28, 2022 | finance.yahoo.com
Should You Investigate Gerresheimer AG (ETR:GXI) At €63.30?
December 12, 2022 | finance.yahoo.com
Institutional investors may adopt severe steps after Gerresheimer AG's (ETR:GXI) latest 11% drop adds to a year losses
November 24, 2022 | finance.yahoo.com
Gerresheimer AG (ETR:GXI) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
November 7, 2022 | finance.yahoo.com
As Gerresheimer (ETR:GXI) climbs 6.7% this past week, investors may now be noticing the company's one-year earnings growth
August 18, 2022 | finanznachrichten.de
Gerresheimer AG: Gerresheimer and Zollner enter into a strategic partnership for electronically controlled medtech systems from a single source
August 13, 2022 | finance.yahoo.com
Gerresheimer AG (GXI.DE)
July 14, 2022 | fxstreet.com
Focus on US CPI data and Fed rate path
June 14, 2022 | finanznachrichten.de
Gerresheimer AG: Gerresheimer partners with MedTech start-up Adamant Health to revolutionize treatment of Parkinson's disease
January 29, 2022 | finanznachrichten.de
Gerresheimer AG: The leading supplier of injection vials Gerresheimer expands production in Wertheim
October 26, 2021 | finance.yahoo.com
Calculating The Intrinsic Value Of Gerresheimer AG (FRA:GXI)
April 8, 2021 | marketwatch.com
European stocks trade around record levels as Fed confirms loose policy stance
February 19, 2021 | finanznachrichten.de
Gerresheimer presents strong fourth quarter
August 17, 2020 | uk.finance.yahoo.com
GERRESHEIMER AG GERRESHEIMER OR (0NTI.IL)
August 13, 2020 | bloomberg.com
Franklin Templeton Investment Funds - Templeton Global Smaller Companies Fund
July 14, 2020 | finance.yahoo.com
Gerresheimer With Strong Second Quarter
June 16, 2020 | finance.yahoo.com
Leading Pharma Packaging Companies Commit to Supply for Covid-19 Fight
May 27, 2020 | finance.yahoo.com
Are Investors Undervaluing Gerresheimer AG (ETR:GXI) By 22%?
See More Headlines

GXI Price History

Industry, Sector and Symbol

Stock Exchange
ETR
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
ETR:GXI
CUSIP
N/A
CIK
N/A
Web
www.gerresheimer.com
Phone
+49-211-618100
Fax
N/A
Employees
10,447
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
€104.12
High Stock Price Forecast
€144.10
Low Stock Price Forecast
€71.00
Forecasted Upside/Downside
+1.3%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

EPS (Most Recent Fiscal Year)
€3.28
Trailing P/E Ratio
31.34
Forward P/E Ratio
18.18
P/E Growth
0.82
Net Income
$97.44 million
Net Margins
5.12%
Pretax Margin
N/A
Return on Equity
9.25%
Return on Assets
3.94%

Debt

Debt-to-Equity Ratio
111.50
Current Ratio
0.87
Quick Ratio
0.40

Sales & Book Value

Annual Sales
$1.90 billion
Price / Sales
1.70
Cash Flow
€6.92 per share
Price / Cash Flow
14.85
Book Value
€36.56 per share
Price / Book
2.81

Miscellaneous

Outstanding Shares
31,400,000
Free Float
N/A
Market Cap
$3.23 billion
Optionable
Not Optionable
Beta
1.02

Key Executives

  • Mr. Dietmar Siemssen (Age 59)
    CEO of Plastics & Devices and Advanced Technologies Division & Chairman of the Management Board
    Comp: $1.91M
  • Dr. Bernd Metzner Ph.D. (Age 52)
    CFO & Member of the Management Board
    Comp: $1.19M
  • Dr. Lukas Burkhardt (Age 43)
    Member of the Management Board
    Comp: $1.16M
  • Ms. Katja Schnitzler (Age 41)
    Member of Supervisory Board
    Comp: $106k
  • Ms. Carolin Nadilo
    Corp. Director of Investor Relations
  • Ueli Utzinger
    Group Sr. Director Marketing & Communication
  • Mr. Helmut Schweiger
    MD & GM of Gerresheimer Horsovsky Tyn Plant

Key Competitors

View All Competitors













GXI Stock - Frequently Asked Questions

What is Gerresheimer's stock price forecast for 2023?

0 Wall Street research analysts have issued twelve-month target prices for Gerresheimer's shares. Their GXI share price forecasts range from €71.00 to €144.10. On average, they predict the company's share price to reach €104.12 in the next year. This suggests a possible upside of 1.3% from the stock's current price.
View analysts price targets for GXI or view top-rated stocks among Wall Street analysts.

How have GXI shares performed in 2023?

Gerresheimer's stock was trading at €62.80 on January 1st, 2023. Since then, GXI stock has increased by 63.7% and is now trading at €102.80.
View the best growth stocks for 2023 here.

Is Gerresheimer a good dividend stock?

Gerresheimer (ETR:GXI) pays an annual dividend of €1.25 per share and currently has a dividend yield of 1.27%. The dividend payout ratio is 38.11%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of Gerresheimer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Gerresheimer investors own include Agilent Technologies (A), Abbott Laboratories (ABT), ACADIA Pharmaceuticals (ACAD), AxoGen (AXGN), Biohaven (BHVN), Blueprint Medicines (BPMC), Cree (CREE), Henkel AG & Co. KGaA (HEN3), Sarepta Therapeutics (SRPT) and Alcoa (AA).

What is Gerresheimer's stock symbol?

Gerresheimer trades on the ETR under the ticker symbol "GXI."

What is Gerresheimer's stock price today?

One share of GXI stock can currently be purchased for approximately €102.80.

How much money does Gerresheimer make?

Gerresheimer (ETR:GXI) has a market capitalization of $3.23 billion and generates $1.90 billion in revenue each year. The company earns $97.44 million in net income (profit) each year or €3.28 on an earnings per share basis.

How many employees does Gerresheimer have?

The company employs 10,447 workers across the globe.

How can I contact Gerresheimer?

Gerresheimer's mailing address is Klaus-Bungert-Strasse 4, DUESSELDORF, 40468, Germany. The official website for the company is www.gerresheimer.com. The company can be reached via phone at +49-211-618100.

This page (ETR:GXI) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -